Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Spatio-temporally controlled induction of gene expression in vivo allows tracking the fate of tumor cells that traffic through the lymphatics.

Grau N, Scherer SD, Rothley M, Roßwag S, Thiele W, Stoecklein NH, Cremers N, Thaler S, Garvalov BK, Sleeman JP.

Int J Cancer. 2019 Nov 1. doi: 10.1002/ijc.32766. [Epub ahead of print]

PMID:
31675122
2.

Tryptophan and Kynurenine Pathway Metabolites in Animal Models of Retinal and Optic Nerve Damage: Different Dynamics of Changes.

Fiedorowicz M, Choragiewicz T, Thaler S, Schuettauf F, Nowakowska D, Wojtunik K, Reibaldi M, Avitabile T, Kocki T, Turski WA, Kaminska A, Grieb P, Zrenner E, Rejdak R, Toro MD.

Front Physiol. 2019 Oct 1;10:1254. doi: 10.3389/fphys.2019.01254. eCollection 2019.

3.

[Credé Prophylaxis - a Purely Gynaecological-Obstetric "Invention"?]

Rohrbach JM, Voykov B, Thaler S.

Klin Monbl Augenheilkd. 2019 May 2. doi: 10.1055/a-0841-3479. [Epub ahead of print] German. No abstract available.

PMID:
31049914
4.

Histopathology of a retrocorneal membrane after Descemet membrane endothelial keratoplasty: a case report.

Bayyoud T, Rohrbach JM, Bartz-Schmidt KU, Thaler S.

J Med Case Rep. 2019 Feb 6;13(1):31. doi: 10.1186/s13256-018-1960-0.

5.

LIPG-promoted lipid storage mediates adaptation to oxidative stress in breast cancer.

Cadenas C, Vosbeck S, Edlund K, Grgas K, Madjar K, Hellwig B, Adawy A, Glotzbach A, Stewart JD, Lesjak MS, Franckenstein D, Claus M, Hayen H, Schriewer A, Gianmoena K, Thaler S, Schmidt M, Micke P, Pontén F, Mardinoglu A, Zhang C, Käfferlein HU, Watzl C, Frank S, Rahnenführer J, Marchan R, Hengstler JG.

Int J Cancer. 2019 Aug 15;145(4):901-915. doi: 10.1002/ijc.32138. Epub 2019 Feb 7.

6.

Seasonal forecasting of green water components and crop yield of summer crops in Serbia and Austria.

Lalić B, Firanj Sremac A, Eitzinger J, Stričević R, Thaler S, Maksimović I, Daničić M, Perišić D, Dekić L.

J Agric Sci. 2018 Jul;156(5):658-672. doi: 10.1017/S0021859618000047. Epub 2018 Feb 14.

7.

Factors influencing the virological testing of cornea donors.

Röck T, Beck R, Jürgens S, Bartz-Schmidt KU, Bramkamp M, Thaler S, Röck D.

Medicine (Baltimore). 2017 Nov;96(47):e8561. doi: 10.1097/MD.0000000000008561.

8.

Proteasome inhibitors prevent bi-directional HER2/estrogen-receptor cross-talk leading to cell death in endocrine and lapatinib-resistant HER2+/ER+ breast cancer cells.

Thaler S, Schmidt M, Roβwag S, Thiede G, Schad A, Sleeman JP.

Oncotarget. 2017 Aug 14;8(42):72281-72301. doi: 10.18632/oncotarget.20261. eCollection 2017 Sep 22.

9.

Allelic Expression Imbalance in the Human Retinal Transcriptome and Potential Impact on Inherited Retinal Diseases.

Llavona P, Pinelli M, Mutarelli M, Marwah VS, Schimpf-Linzenbold S, Thaler S, Yoeruek E, Vetter J, Kohl S, Wissinger B.

Genes (Basel). 2017 Oct 20;8(10). pii: E283. doi: 10.3390/genes8100283.

10.

Effect of Organ Scandal on Corneal Donation Rate and Organ Donors at a German University Hospital.

Röck D, Petersen P, Yoeruek E, Thaler S, Bartz-Schmidt KU, Röck T.

Ann Transplant. 2017 Jul 11;22:425-430.

11.

Factors influencing the contamination rate of human organ-cultured corneas.

Röck D, Wude J, Bartz-Schmidt KU, Yoeruek E, Thaler S, Röck T.

Acta Ophthalmol. 2017 Dec;95(8):e706-e712. doi: 10.1111/aos.13375. Epub 2017 Mar 21.

12.

'Normalizing' the malignant phenotype of luminal breast cancer cells via alpha(v)beta(3)-integrin.

Abu-Tayeh H, Weidenfeld K, Zhilin-Roth A, Schif-Zuck S, Thaler S, Cotarelo C, Tan TZ, Thiery JP, Green JE, Klorin G, Sabo E, Sleeman JP, Tzukerman M, Barkan D.

Cell Death Dis. 2016 Dec 1;7(12):e2491. doi: 10.1038/cddis.2016.387.

13.

Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes.

Cotarelo CL, Schad A, Kirkpatrick CJ, Sleeman JP, Springer E, Schmidt M, Thaler S.

Oncotarget. 2016 Nov 15;7(46):74846-74859. doi: 10.18632/oncotarget.12432.

14.

Cycles of insanity and creativity within contemplative neural systems.

Thaler SL.

Med Hypotheses. 2016 Sep;94:138-47. doi: 10.1016/j.mehy.2016.07.010. Epub 2016 Jul 16.

PMID:
27515220
15.

Digital Family History Data Mining with Neural Networks: A Pilot Study.

Hoyt R, Linnville S, Thaler S, Moore J.

Perspect Health Inf Manag. 2016 Jan 1;13:1c. eCollection 2016.

16.

[Commentary for Letter to the Editor on Anterior Chamber Antibiotic Treatment].

Röck T, Bramkamp M, Bartz-Schmidt KU, Mutlu U, Yörük E, Röck D, Thaler S.

Klin Monbl Augenheilkd. 2015 Dec;232(12):1423. doi: 10.1055/s-0035-1558253. Epub 2015 Dec 17. German. No abstract available.

PMID:
26678906
17.

Surgical treatment of open globe trauma complicated with the presence of an intraocular foreign body.

Chorągiewicz T, Nowomiejska K, Wertejuk K, Koss MJ, Thaler S, Sorrentino S, Forlini M, Jünemann AG, Rejdak R.

Klin Oczna. 2015;117(1):5-8.

PMID:
26349150
18.

Factors that influence the suitability of human organ-cultured corneas.

Röck T, Hofmann J, Thaler S, Bramkamp M, Bartz-Schmidt KU, Yoeruek E, Röck D.

Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):135-41. doi: 10.1007/s00417-015-3119-7. Epub 2015 Aug 20.

PMID:
26287265
19.

Ketogenic diet attenuates NMDA-induced damage to rat's retinal ganglion cells in an age-dependent manner.

Zarnowski T, Choragiewicz TJ, Schuettauf F, Zrenner E, Rejdak R, Gasior M, Zarnowska I, Thaler S.

Ophthalmic Res. 2015;53(3):162-7. doi: 10.1159/000379753. Epub 2015 Mar 27.

PMID:
25832811
20.

The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.

Thaler S, Thiede G, Hengstler JG, Schad A, Schmidt M, Sleeman JP.

Int J Cancer. 2015 Aug 1;137(3):686-97. doi: 10.1002/ijc.29404. Epub 2015 Jan 8.

21.

In vivo biocompatibility of a new cyanine dye for ILM peeling.

Thaler S, Haritoglou C, Schuettauf F, Choragiewicz T, May CA, Gekeler F, Fischer MD, Langhals H, Schatz A.

Eye (Lond). 2015 Mar;29(3):428-35. doi: 10.1038/eye.2014.295. Epub 2014 Dec 19.

22.

[Using intracameral cefuroxime reduces postoperative endophthalmitis rate: 5 years experience at the University Eye Hospital Tübingen].

Röck T, Bramkamp M, Bartz-Schmidt KU, Mutlu U, Yörük E, Röck D, Thaler S.

Klin Monbl Augenheilkd. 2014 Oct;231(10):1023-8. doi: 10.1055/s-0034-1383013. Epub 2014 Oct 21. German.

PMID:
25333241
23.

Age-dependent neuroprotection of retinal ganglion cells by tempol-C8 acyl ester in a rat NMDA toxicity model.

Fiedorowicz M, Rejdak R, Schuettauf F, Wozniak M, Grieb P, Thaler S.

Folia Neuropathol. 2014;52(3):291-7.

24.

Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina.

Januschowski K, Mueller S, Dollinger R, Schnichels S, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Thaler S.

Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):935-41. doi: 10.1007/s00417-014-2632-4. Epub 2014 May 2.

PMID:
24789463
25.

[Neuroprotective approaches].

Thaler S, Haritoglou C, Schuettauf F.

Ophthalmologe. 2013 Oct;110(10):941-7. doi: 10.1007/s00347-013-2831-0. Review. German.

PMID:
24046168
26.

Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats.

Thiele W, Rothley M, Teller N, Jung N, Bulat B, Plaumann D, Vanderheiden S, Schmaus A, Cremers N, Göppert B, Dimmler A, Eschbach V, Quagliata L, Thaler S, Marko D, Bräse S, Sleeman JP.

Carcinogenesis. 2013 Dec;34(12):2804-13. doi: 10.1093/carcin/bgt291. Epub 2013 Aug 23.

PMID:
23975834
27.

Presence and distribution of L-kynurenine aminotransferases immunoreactivity in human cataractous lenses.

Rejdak R, Oleszczuk A, Rummelt C, Turski WA, Choragiewicz T, Nowomiejska K, Ksiazek K, Thaler S, Zarnowski T, Okuno E, Grieb P, Zrenner E, Kruse F, Junemann AG.

Acta Ophthalmol. 2013 Sep;91(6):e450-5. doi: 10.1111/aos.12138. Epub 2013 Apr 17.

28.

[Drug-induced malignant arrhythmias. IT prevents lethal drug mixtures].

Thaler S, Neumeier C, Flury G.

Internist (Berl). 2013 Apr;54(4):485-90. doi: 10.1007/s00108-013-3246-3. German.

PMID:
23460391
29.

Tempol protects against intravitreous indocyanine green-induced retinal damage in rats.

Thaler S, Voykov B, Willmann G, Fiedorowicz M, Rejdak R, Gekeler F, May CA, Schatz A, Schuettauf F.

Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1597-606. doi: 10.1007/s00417-012-2000-1. Epub 2012 Mar 31.

PMID:
22460632
30.

Considerations on methodological challenges for water footprint calculations.

Thaler S, Zessner M, De Lis FB, Kreuzinger N, Fehringer R.

Water Sci Technol. 2012;65(7):1258-64. doi: 10.2166/wst.2012.006.

PMID:
22437024
31.

Synthesis, staining properties, and biocompatibility of a new cyanine dye for ILM peeling.

Haritoglou C, Kernt M, Laubichler P, Langhals H, Eibl K, Varja A, Thaler S, Kampik A.

Graefes Arch Clin Exp Ophthalmol. 2012 Jun;250(6):829-38. doi: 10.1007/s00417-012-1959-y. Epub 2012 Feb 23.

PMID:
22395201
32.

Kynurenic acid and kynurenine aminotransferases in retinal aging and neurodegeneration.

Rejdak R, Junemann A, Grieb P, Thaler S, Schuettauf F, Chorągiewicz T, Zarnowski T, Turski WA, Zrenner E.

Pharmacol Rep. 2011;63(6):1324-34. Review.

33.

Decellularized bovine corneal posterior lamellae as carrier matrix for cultivated human corneal endothelial cells.

Bayyoud T, Thaler S, Hofmann J, Maurus C, Spitzer MS, Bartz-Schmidt KU, Szurman P, Yoeruek E.

Curr Eye Res. 2012 Mar;37(3):179-86. doi: 10.3109/02713683.2011.644382.

PMID:
22335804
34.

RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.

Thaler S, Schmidt M, Schad A, Sleeman JP.

Oncogene. 2012 Nov 22;31(47):4912-22. doi: 10.1038/onc.2011.658. Epub 2012 Jan 23.

PMID:
22266866
35.

Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats.

Żarnowski T, Chorągiewicz T, Tulidowicz-Bielak M, Thaler S, Rejdak R, Żarnowski I, Turski WA, Gasior M.

J Neural Transm (Vienna). 2012 Jun;119(6):679-84. doi: 10.1007/s00702-011-0750-2. Epub 2011 Dec 27.

36.

Presence of L-kynurenine aminotransferase III in retinal ganglion cells and corpora amylacea in the human retina and optic nerve.

Rejdak R, Rummelt C, Zrenner E, Grieb P, Rejdak K, Okuno E, Thaler S, Nowomiejska K, Kruse F, Turski W, Junemann AG.

Folia Neuropathol. 2011;49(2):132-7.

37.

[Clinical results after cataract surgery in patients with Behçet's disease].

Saygili O, Szurman P, Gieselmann S, Deuter C, Spitzer MS, Thaler S, Bartz-Schmidt KU, Yoeruek E.

Klin Monbl Augenheilkd. 2011 Oct;228(10):900-4. doi: 10.1055/s-0029-1245964. Epub 2011 Jun 8. German.

PMID:
21656461
38.

Neuroprotective effects of tempol acyl esters against retinal ganglion cell death in a rat partial optic nerve crush model.

Thaler S, Fiedorowicz M, Grieb P, Wypych Z, Knap N, Borowik T, Zawada K, Kaminski J, Wozniak M, Rejdak R, Zrenner E, Schuettauf F.

Acta Ophthalmol. 2011 Nov;89(7):e555-60. doi: 10.1111/j.1755-3768.2011.02180.x. Epub 2011 Jun 3.

39.

Methyl blue and aniline blue versus patent blue and trypan blue as vital dyes in cataract surgery: capsule staining properties and cytotoxicity to human cultured corneal endothelial cells.

Thaler S, Hofmann J, Bartz-Schmidt KU, Schuettauf F, Haritoglou C, Yoeruek E.

J Cataract Refract Surg. 2011 Jun;37(6):1147-53. doi: 10.1016/j.jcrs.2010.12.051.

PMID:
21596258
40.

Caspase inhibitors protect against NMDA-mediated retinal ganglion cell death.

Schuettauf F, Stein T, Choragiewicz TJ, Rejdak R, Bolz S, Zurakowski D, Varde MA, Laties AM, Thaler S.

Clin Exp Ophthalmol. 2011 Aug;39(6):545-54. doi: 10.1111/j.1442-9071.2010.02486.x. Epub 2011 Feb 23.

PMID:
21176044
41.

Considerations on the importance of nutrition habits for the national nitrogen balance of Austria.

Zessner M, Thaler S, Ruzicka K, Natho S, Kroiss H.

Water Sci Technol. 2010;62(1):21-7. doi: 10.2166/wst.2010.270.

PMID:
20595749
42.

Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid.

Thaler S, Choragiewicz TJ, Rejdak R, Fiedorowicz M, Turski WA, Tulidowicz-Bielak M, Zrenner E, Schuettauf F, Zarnowski T.

Graefes Arch Clin Exp Ophthalmol. 2010 Dec;248(12):1729-35. doi: 10.1007/s00417-010-1425-7. Epub 2010 Jun 8.

43.

Toxicity testing of the VEGF inhibitors bevacizumab, ranibizumab and pegaptanib in rats both with and without prior retinal ganglion cell damage.

Thaler S, Fiedorowicz M, Choragiewicz TJ, Bolz S, Tura A, Henke-Fahle S, Yoeruek E, Zrenner E, Bartz-Schmidt KU, Ziemssen F, Schuettauf F.

Acta Ophthalmol. 2010 Aug;88(5):e170-6. doi: 10.1111/j.1755-3768.2010.01927.x. Epub 2010 May 14.

44.

Intermediate uveitis and arthralgia as early symptoms in Whipple's disease.

Thaler S, Grisanti S, Klingel K, Raible A, Kempf VA, Schulte B.

Int J Infect Dis. 2010 Sep;14 Suppl 3:e388-9. doi: 10.1016/j.ijid.2009.11.038. Epub 2010 Apr 18. No abstract available.

45.

Effects of bevacizumab on apoptosis, Na+ -K+ -adenosine triphosphatase and zonula occludens 1 expression on cultured corneal endothelial cells.

Yoeruek E, Tatar O, Spitzer MS, Saygili O, Biedermann T, Bartz-Schmidt KU, Thaler S, Szurman P.

Ophthalmic Res. 2010;44(1):43-9. doi: 10.1159/000286339. Epub 2010 Feb 19.

PMID:
20173357
46.

Experimental evaluation of aniline and methyl blue for intraocular surgery.

Haritoglou C, Priglinger S, Liegl R, May CA, Eibl K, Thaler S, Kampik A, Schuettauf F.

Retina. 2009 Oct;29(9):1266-73. doi: 10.1097/IAE.0b013e3181b8626f.

PMID:
19934821
47.

In vivo toxicity testing of methyl blue and aniline blue as vital dyes for intraocular surgery.

Thaler S, Schuettauf F, Fiedorowicz M, Messias A, Schatz A, Choragiewicz TJ, May CA, Zrenner E, Kampik A, Haritoglou C.

Retina. 2009 Oct;29(9):1257-65. doi: 10.1097/IAE.0b013e3181b8615b.

PMID:
19934820
48.

Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load.

Thaler S, Fiedorowicz M, Rejdak R, Choragiewicz TJ, Sulejczak D, Stopa P, Zarnowski T, Zrenner E, Grieb P, Schuettauf F.

Exp Eye Res. 2010 Feb;90(2):254-60. doi: 10.1016/j.exer.2009.10.013. Epub 2009 Nov 4.

PMID:
19883642
49.

A novel biomarker for retinal degeneration: vitreous body neurofilament proteins.

Petzold A, Junemann A, Rejdak K, Zarnowski T, Thaler S, Grieb P, Kruse FE, Zrenner E, Rejdak R.

J Neural Transm (Vienna). 2009 Dec;116(12):1601-6. doi: 10.1007/s00702-009-0316-8. Epub 2009 Sep 22.

PMID:
19771389
50.

RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt.

Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M.

Cancer Res. 2009 Mar 1;69(5):1748-57. doi: 10.1158/0008-5472.CAN-08-1377. Epub 2009 Feb 17.

Supplemental Content

Loading ...
Support Center